Ernexa Therapeutics Inc. (ERNA) Revenue 2016–2025
Ernexa Therapeutics Inc. (ERNA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$582,000FY2025 · since FY2016: $24.5M → $582,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $582,000 | +755.9% |
| FY2024 | $68,000 | — |
| FY2023 | $0 | — |
| FY2021 | $5.8M | -70.7% |
| FY2020 | $19.8M | -15.1% |
| FY2019 | $23.3M | +9.7% |
| FY2018 | $21.3M | -4.7% |
| FY2017 | $22.3M | -9.0% |
| FY2016 | $24.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ERNA financial trends
ERNA Net incomeERNA Net marginERNA Gross profitERNA Gross marginERNA Operating incomeERNA Operating marginERNA Operating cash flowERNA Free cash flowERNA Capital expendituresERNA Return on equityERNA Stock buybacksERNA Dividends paidERNA Total assetsERNA Total liabilitiesERNA Shareholders’ equityERNA overview →